Technical Description
This technology is a cost-effective and biocompatible inorganic complex generating reactive oxygen species (ROS) under ultrasound exposure for therapeutic applications.
Problems Addressed
- Inefficient Preparation
- Lacks Clinical Translation
- Inefficient Biosafety Evaluation
- Lacks Therapeutic Penetration
- LLimited Light Penetration
- Inefficient Anticancer Efficacy
Tech Features
- Efficient ROS Generation
- Enhanced Ultrasound Activation
- Better Tissue Penetration
- Efficient Cancer Therapy
- Enhanced Stability
- Better Biocompatibility
Target Audience
- Pharmaceutical Companies
- Biotechnology Firms
- Medical Device Companies
- Healthcare Providers
- Academic & Research Institutions
Tech ID: P21-1518 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
